How to buy LHC Group stock | $146.82

LHC Group Inc is a medical care facilities business based in the US. LHC Group shares (LHCG) are listed on the NASDAQ and all prices are listed in US Dollars. LHC Group employs 30,000 staff and has a trailing 12-month revenue of around 0.00.

LHC Group stock price (NASDAQ: LHCG)

Use our graph to track the performance of LHCG stocks over time.

LHC Group shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$146.82
52-week range	$133.74 - $236.81
50-day moving average	$162.69
200-day moving average	$190.12
Wall St. target price	$217.62
PE ratio	38.9708
Dividend yield	N/A (0%)
Earnings per share (TTM)	$3.73

Buy LHC Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy LHC Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LHC Group price performance over time

Historical closes compared with the close of $146.82 from 2021-10-18

1 week (2021-10-12)	6.91%
1 month (2021-09-17)	-13.11%
3 months (2021-07-19)	-28.03%
6 months (2021-04-19)	-28.29%

1 year (2020-10-16)	-34.71%
2 years (2019-10-18)	25.99%
3 years (2018-10-18)	61.62%
5 years (2016-10-18)	292.67%

Is LHC Group under- or over-valued?

Valuing LHC Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LHC Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LHC Group's P/E ratio

LHC Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, LHC Group shares trade at around 39x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LHC Group's PEG ratio

LHC Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2859. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LHC Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LHC Group's EBITDA

LHC Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $248.8 million.

The EBITDA is a measure of a LHC Group's overall financial performance and is widely used to measure a its profitability.

LHC Group financials

Revenue TTM	$2.1 billion
Operating margin TTM	10.71%
Gross profit TTM	$812.8 million
Return on assets TTM	6.04%
Return on equity TTM	8.57%
Profit margin	5.49%
Book value	$51.13
Market capitalisation	$4.6 billion

TTM: trailing 12 months

Shorting LHC Group shares

There are currently 975,823 LHC Group shares held short by investors – that's known as LHC Group's "short interest". This figure is 4.5% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting LHC Group shares can be evaluated.

LHC Group's "short interest ratio" (SIR)

LHC Group's "short interest ratio" (SIR) is the quantity of LHC Group shares currently shorted divided by the average quantity of LHC Group shares traded daily (recently around 229605.41176471). LHC Group's SIR currently stands at 4.25. In other words for every 100,000 LHC Group shares traded daily on the market, roughly 4250 shares are currently held short.

However LHC Group's short interest can also be evaluated against the total number of LHC Group shares, or, against the total number of tradable LHC Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LHC Group's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 LHC Group shares in existence, roughly 30 shares are currently held short) or 0.0322% of the tradable shares (for every 100,000 tradable LHC Group shares, roughly 32 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against LHC Group.

Find out more about how you can short LHC Group stock.

LHC Group share dividends

We're not expecting LHC Group to pay a dividend over the next 12 months.

LHC Group share price volatility

Over the last 12 months, LHC Group's shares have ranged in value from as little as $133.74 up to $236.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LHC Group's is 0.4455. This would suggest that LHC Group's shares are less volatile than average (for this exchange).

LHC Group overview

LHC Group, Inc. , a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations.

Frequently asked questions

What percentage of LHC Group is owned by insiders or institutions?
Currently 4.404% of LHC Group shares are held by insiders and 96.754% by institutions. How many people work for LHC Group?
Latest data suggests 30,000 work at LHC Group. When does the fiscal year end for LHC Group?
LHC Group's fiscal year ends in December. Where is LHC Group based?
LHC Group's address is: 901 Hugh Wallis Road South, Lafayette, LA, United States, 70508 What is LHC Group's ISIN number?
LHC Group's international securities identification number is: US50187A1079 What is LHC Group's CUSIP number?
LHC Group's Committee on Uniform Securities Identification Procedures number is: 50187A107